Download PDF
Ernährung & Medizin 2004; 19(1): 11-15
DOI: 10.1055/s-2004-822856
Konjugierte Linolsäuren

© Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Biologische Wirksamkeit von konjugierten Linolsäuren

Biological effects of conjugated linoleic acidsKarl-Heinz Wagner
Further Information

Publication History

Publication Date:
04 December 2006 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Konjugierte Linolsäuren (CLA) sind im Gegensatz zu Linolsäure hauptsächlich in tierischen Produkten wie Fleisch, Wurst, Milch oder Milchprodukten zu finden. Für CLA werden verschiedene biologische und physiologische Wirkungen diskutiert, die jedoch hauptsächlich auf Zell- und Tierebene gezeigt wurden. Dies gilt vor allem für ihre antikarzinogene Wirkung, die mit beiden Systemen bestätigt wurde. Verschiedene Studien an Tieren zeigen antithrombotische, aber auch prothrombotische Effekte von CLA. Weiters gibt es im Tierversuch Hinweise auf eine antidiabetogene Wirkung. An Tiermodellen, vereinzelt auch schon in Humanstudien, konnte eine Reduktion des Körperfettanteils und eine Induktion der mageren Körpermasse gezeigt werden; die Ergebnisse im Humanbereich sind jedoch widersprüchlich und basieren auf kurz- und mittelfristig angelegten Studien. Daten von Langzeitinterventionen fehlen ebenso wie eine gesicherte Risikoabschätzung, trotz der Tatsache, dass erste Daten zur Sicherheitsbeurteilung kürzlich publiziert wurden. Bis heute gibt es Hinweise auf vielfältige protektive Effekte von CLA vor allem in Zell- und Tiermodellen, jedoch müssen Langzeitinterventionsstudien an Menschen diese positiven Wirkungen noch nachhaltig bestätigen.

Summary

In contrast with linoleic acids, conjugated linoleic acids (CLA) are mainly found in animal products such as meat, milk or milk products. Different biological and physiological effects are attributed to CLA which, however, could only be demonstrated in cell and animal studies. In particular, anticarcinogenic effects were found in both systems. Several animal studies resulted in both antithrombotic and prothrombotic effects. In addition, antidiabetic effects were found. Mainly the results of animal studies, but also those of some human studies, indicate that CLA also reduces the overall fat content and increases the lean body mass. However, these results, particular of human studies, are controversial and only based on short-term studies. Data on long-term studies are missing as are safe risk assessments even though first safety assessments have been published recently. Multiple protective effects of CLA, especially those found in cell and animal studies, are assumed, but positive effects on humans will have to be confirmed by long-term studies.

Schlüsselwörter

Konjugierte Linolsäuren - Zell- und Tierstudien - biologische Effekte - Sicherheit

Key words

Conjugated linoleic acid - cell and animal studies - biological effects - safety assessment

Literatur

  • 1 Kim EJ, Holthuizen PE, Park HS. et al. . Trans-10, cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth.  Am J Physiol Gastrointest Liver. 2002;  283 357-367
    PubMedGoogle Scholar
  • 2 Eder K, Slomma N, Becker K. Trans-10,cis-12 conjugated linoleic acid suppresses the desaturation of linoleic and alpha-linolenic acids in HepG2 cells.  J Nutr. 2002;  132 1115-1121
    PubMedGoogle Scholar
  • 3 Ip C, Banni S, Angioni E. et al. . Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats.  J Nutr. 1999;  129 2135-2142
    PubMedGoogle Scholar
  • 4 Cornell KK, Waters DJ, Coffman KT, Robinson JP, Watkins BA. Conjugated linoleic acid inhibited the in vitro proliferation of canine prostate cancer cells.  FASEB J. 1997;  11 579
    PubMedGoogle Scholar
  • 5 Cho HJ, Kim WK, Kim EJ. et al. . Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line.  Am J Physiol Gastrointest Liver Physiol. 2003;  284 996-1005
    PubMedGoogle Scholar
  • 6 Miller A, Stanton C, Devery R. Cis 9, trans 11- and trans 10, cis 12-conjugated linoleic acid isomers induce apoptosis in cultured SW480 cells.  Anticancer Res. 2002;  22 3879-3887
    PubMedGoogle Scholar
  • 7 Park Y. Regulation of energy metabolism and the catabolic effects on immune stimulation by conjugated linoleic acid [Ph.D. Dissertation]. University of Wisconsin, Madison 1996
    Google Scholar
  • 8 Ma DW, Field CJ, Clandinin MT. An enriched mixture of trans-10,cis-12-CLA inhibits linoleic acid metabolism and PGE2 synthesis in MDA-MB-231 cells.  Nutr Cancer. 2002;  44 203-212
    PubMedGoogle Scholar
  • 9 Evans M, Park Y, Pariza M. et al. . Trans-10, cis-12 conjugated linoleic acid reduces triglyceride content while differentially affecting peroxisome proliferator activated receptor gamma2 and aP2 expression in 3T3-L1 preadipocytes.  Lipids. 2001;  36 1223-1232
    PubMedGoogle Scholar
  • 10 Yu Y, Correll PH, Vanden JP Heuvel. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism.  Biochim Biophys Acta. 2002;  1581 89-99
    PubMedGoogle Scholar
  • 11 Ip C, Briggs SP, Haegele AD. et al. . The efficacy of conjugated linoleic acid in mammary cancer prevention is independent of the level or type of fat in the diet.  Carcinogenesis. 1996;  17 1045-1050
    PubMedGoogle Scholar
  • 12 Brown JM, Boysen MS, Jensen SS. et al. . Trans-10, cis-12 conjugated linoleic acid decreases glucose and fatty acid uptake and oxidation and inhibits PPARgamma-dependent gene expression in human preadipocytes.  J Lipid Res. 2003;  44 1287-1300
    PubMedGoogle Scholar
  • 13 Hubbard NE, Lim D, Summers L, Erickson KL. Reduction of murine mammary tumor metastasis by conjugated linoleic acid.  Cancer Lett. 2000;  150 93-100
    CrossrefPubMedGoogle Scholar
  • 14 Futakuchi M, Cheng JL, Hirose M. et al. . Inhibition of conjugated fatty acids derived from safflower or perilla oil of induction and development of mammary tumors in rats induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).  Cancer Lett. 2002;  178 131-139
    CrossrefPubMedGoogle Scholar
  • 15 Yang H, Glickman BW, de Boer JG. Effect of conjugated linoleic acid on the formation of spontaneous and PhIP-induced mutation in the colon and cecum of rats.  Mutat Res. 2002;  500 157-168
    PubMedGoogle Scholar
  • 16 Yang H, Holcroft J, Glickman BW, De Boer JG. Conjugated linoleic acid inhibits mutagenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the prostate of Big Blue((R)) rats.  Mutagenesis. 2003;  18 195-200
    CrossrefPubMedGoogle Scholar
  • 17 Kraft J, Jahreis G. Konjugierte Linolsäuren: Genese und metabolische Wirkungen.  Ernährungs-Umschau. 2001;  48 348-355
    PubMedGoogle Scholar
  • 18 Yanagita T, Nagao K, Wang M. et al. .The 10trans,12cisisomer of Conjugated Linoleic Acid Promotes Energy Metabolism and Improves Obesity and Lipid Metabolism in Obese OLETF Rats. 94th AOCS Congress, 4-7 May, 2003, Kansas, USA
    Google Scholar
  • 19 Gavino VC, Gavino G, Leblanc MJ, Tuchweber B. An isomeric mixture of conjugated linoleic acids but not pure cis-9,trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters.  J Nutr. 2000;  130 27-29
    PubMedGoogle Scholar
  • 20 Munday JS, Thompson KG, James KAC. Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model.  Br J Nutr. 1999;  81 251-255
    PubMedGoogle Scholar
  • 21 Alasnier C, Berdeaux O, Chardigny JM, Sebedio JL. Fatty acid composition and conjugated linoleic acid content of different tissues in rats fed individual conjugated linoleic acid isomers given as triacylglycerols small star, filled.  J Nutr Biochem. 2002;  13 337-345
    PubMedGoogle Scholar
  • 22 Xu X, Storkson J, Kim S. et al. . Short-term intake of conjugated linoleic acid inhibits lipoprotein lipase and glucose metabolism but does not enhance lipolysis in mouse adipose tissue.  J Nutr. 2003;  133 663-667
    PubMedGoogle Scholar
  • 23 Pariza MW, Park Y, Cook ME. Mechanisms of action of conjugated linoleic acid: evidence and speculation.  Proc Soc Exp Biol Med. 2000;  223 8-13
    CrossrefPubMedGoogle Scholar
  • 24 Whigham LD, Higbee AJ, Pariza MW, Cook ME. Influence of dietary conjugated linoleic acid on release of PGE2 and LTB4 from giunea pig lung, trachea, and bladder.  FASEB J. 1998;  12 819
    PubMedGoogle Scholar
  • 25 Ryder JW, Portocarrero CP, Song XM. et al. . Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression.  Diabetes. 2001;  50 1149-1157
    PubMedGoogle Scholar
  • 26 Houseknecht KL, Vanden JP Heuvel, Moya-Camarena SY. et al. . Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat.  Biochem Biophys Res Commun. 1998;  244 678-682
    CrossrefPubMedGoogle Scholar
  • 27 Henriksen EJ, Teachey MK, Taylor ZC. et al. . Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat.  Am J Physiol Endocrinol Metab. 2003;  285 98-105
    PubMedGoogle Scholar
  • 28 Schulte S, Hasselwander O, Rensmann FW, Kaesler B, Pfeiffer AM. Safety Assessment of Conjugated Linoleic Acid (CLA) Esters in the Future Application Field as a Feed Additive in Growing Pigs. 94th AOCS Congress, 4-7 May, 2003, Kansas, USA
    Google Scholar
  • 29 Pfeiffer AM, Kaufmann W, Braun J, Kaesler B. Target Animal Safety of Conjugated Linoleic Acid (CLA) on Young Growing Pigs. 94th AOCS Congress, 4-7 May, 2003, Kansas, USA
    Google Scholar
  • 30 Thom E. A pilot study with the aim of studying the efficacy and tolerability of tonalin CLA on the body composition in humans. Medstat Research Ltd., Lillestrøm, Norway 1998
    Google Scholar
  • 31 Zambell KL, Keim NL, Van MD Loan. et al. . Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure.  Lipids. 2000;  35 777-782
    PubMedGoogle Scholar
  • 32 Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans - metabolic effects.  Lipids. 2001;  36 773-781
    PubMedGoogle Scholar
  • 33 Mougios V, Matsakas A, Petridou A. et al. . Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat.  J Nutr Biochem. 2001;  12 585-594
    PubMedGoogle Scholar
  • 34 Mougios V, Petridou A, Matsakas A. Effect of Supplementation with CLA on Human Body Fat and Incorporation into Serum Lipid Classes. 94th AOCS Congress, 4-7 May, 2003, Kansas, USA
    Google Scholar
  • 35 Medina EA, Horn WF, Keim NL. et al. . Conjugated linoleic acid supplementation in humans: effects on circulating leptin concentrations and appetite.  Lipids. 2000;  35 783-788
    PubMedGoogle Scholar
  • 36 Blankson H, Stakkestad JA, Fagertun H. et al. . Conjugated linoleic acid reduces body fat mass in overweight and obese humans.  J Nutr. 2000;  130 2943-2948
    PubMedGoogle Scholar
  • 37 Kelley DS, Taylor PC, Rudolph IL. et al. . Dietary conjugated linoleic acid did not alter immune status in young healthy women.  Lipids. 2000;  35 1065-1071
    PubMedGoogle Scholar
  • 38 Belury MA, Mahon A, Banni S. The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus.  J Nutr. 2003;  133 257-260
    PubMedGoogle Scholar
  • 39 Atkinson RL, Whigham LD. Effects of CLA on Body Composition and Metabolic Variables in Humans. 94th AOCS Congress, 4-7 May, 2003, Kansas, USA
    Google Scholar
  • 40 Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome.  Diabetes Care. 2002;  25 1516-1521
    PubMedGoogle Scholar
  • 41 Riserus U, Basu S, Jovinge S. et al. . Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance.  Circulation. 2002;  106 1925-1929
    CrossrefPubMedGoogle Scholar
  • 42 Rockway S, Tangney C. Dietary Conjugated Linoleic Acid Enhances Body Composition and Lipid Profile in Healthy Overweight Men. 94th AOCS Congress, 4-7 May, 2003, Kansas, USA
    Google Scholar
  • 43 Song HJ, Mohede I, Rotondo D, Grant I, Wahle KW. Regulation of Immune Function by ClarinolTM Conjugated Linoleic Acid in Human Volunteers ex vivo and in Human Cells in vitro. 94th AOCS Congress, 4-7 May, 2003, Kansas, USA
    Google Scholar
  • 44 Albers R, Van Der Wielen RP, Brink EJ. et al. . Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men.  Eur J Clin Nutr. 2003;  57 595-603
    CrossrefPubMedGoogle Scholar
  • 45 Benito P, Nelson GJ, Kelley DS. et al. . The effect of conjugated linoleic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans.  Lipids. 2001;  36 221-227
    PubMedGoogle Scholar
  • 46 Benito P, Nelson GJ, Kelley DS. et al. . The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans.  Lipids. 2001;  36 229-236
    PubMedGoogle Scholar
  • 47 Berven G, Bye A, Hals O. et al. . Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers.  Eur J Lipid Sci Technol. 2000;  102 455-462
    CrossrefPubMedGoogle Scholar
  • 48 Gaullier JM, Berven G, Blankson H, Gudmundsen O. Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies.  Lipids. 2002;  37 1019-1025
    PubMedGoogle Scholar
  • 49 Basu S, Smedman A, Vessby B. Conjugated linoleic acid induces lipid peroxidation in humans.  FEBS Lett. 2000;  468 33-36
    CrossrefPubMedGoogle Scholar
  • 50 Yu L, Adams D, Gabel M. Conjugated linoleic acid isomers differ in their free radical scavenging properties.  J Agric Food Chem. 2002;  50 4135-4140
    CrossrefPubMedGoogle Scholar

1 LD50 = Letaldosis 50; Dosis, die bei der Hälfte der Tiere tödlich wirkt; jeder LD50-Wert gilt nur für die jeweilige Tierart und den jeweiligen Applikationsweg.

Dr. Karl-Heinz Wagner

Institut für Ernährungswissenschaften der Universität Wien

Althanstraße 14

A-1090 Wien

Email: karl-heinz.wagner@univie.ac.at